Woburn, MA-based Intrinsic Therapeutics has rounded up $18 million out of a $20 million offering. Though the filing didn't name investors, previous investors New Enterprise Associates, Spray Venture Partners, and New Leaf Venture Partners are listed as company directors in the SEC filing. The device maker markets a prosthetic to treat disc herniation. Article | Report